Type 2 diabetes with other specified/multiple/unspecified complications

DOID MESH PheWeb

No definition available.

Endpoint definition

↥

FinnGen phenotype data

Filter registries Inpat., Oupat., Death, KELA purch., KELA reimb.

Hospital Discharge: ICD-10 E11.6, E11.6+M14.2, E11.6+M14.6, E11.7, E11.8

Hospital discharge: ICD-9 2507A|2508A

Cause of death: ICD-10 E11.6, E11.6+M14.2, E11.6+M14.6, E11.7, E11.8

Cause of death: ICD-9 2507A|2508A

KELA reimbursements: KELA codes ANY

KELA reimbursements: ICD-10 E11

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

E4_DM2NASCOMP

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF3

Similar endpoints

↥

List of similar endpoints to Type 2 diabetes with other specified/multiple/unspecified complications based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	30099	13408	16691
Unadjusted prevalence (%)	11.58	9.12	14.76
Mean age at first event (years)	61.42	61.12	61.67

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.05	3.35 [2.97, 3.77]	4.1e-88	3694
15 years	0.02	3.54 [3.19, 3.93]	<1e-100	3289
5 years	0.01	5.52 [5.01, 6.07]	<1e-100	1642
1 year	0.00	10.45 [9.05, 12.07]	<1e-100	609

Correlations

↥

Index endpoint: E4_DM2NASCOMP – Type 2 diabetes with other specified/multiple/unspecified complications
GWS hits: 94

Survival analyses between endpoints

↥

Plot

before Type 2 diabetes with other specified/multiple/unspecified complications
after Type 2 diabetes with other specified/multiple/unspecified complications

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Type 2 diabetes with other specified/multiple/unspecified complications

↥